US2021386334A1PendingUtilityA1
Continuous analyte measurement systems and systems and methods for implanting them
Est. expiryJul 23, 2029(~3 yrs left)· nominal 20-yr term from priority
A61B 2560/0443A61B 2562/227A61B 5/002A61B 5/6833A61B 5/14865A61B 5/1495A61B 5/14532A61B 5/7221
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An analyte monitoring system, comprising:
a base unit configured to be mounted on a skin surface; an analyte sensor comprising a proximal portion configured to be positioned within the base unit and a distal portion configured to be inserted through the skin surface, wherein the analyte sensor is configured to detect analyte levels in a bodily fluid of a user; one or more memories comprising a drift correction factor of the analyte sensor and a factory-determined sensitivity; a communication link operatively coupled to the analyte sensor and configured to communicate data corresponding to the analyte levels; and a receiver unit comprising a display and configured to receive the data corresponding to the analyte levels from the communication link; wherein the analyte monitoring system is configured to determine the analyte levels using at least the drift correction factor and the factory-determined sensitivity.
2 . The system of claim 1 , further comprising a conductive member positionable within the base unit and in electrical contact with the analyte sensor.
3 . The system of claim 2 , wherein the base unit comprises a cradle therein for receiving and holding the conductive member.
4 . The system of claim 3 , wherein the conductive member comprises a conductive core and an insulating shell covering the conductive core.
5 . The system of claim 1 , wherein the base unit is configured to mechanically and electrically couple the analyte sensor with the communication link.
6 . The system of claim 1 , wherein the base unit comprises an adhesive bottom for adhering to the skin surface.
7 . The system of claim 1 , wherein the base unit comprises an opening therein through which the distal portion of the analyte sensor extends.
8 . The system of claim 1 , wherein the analyte sensor does not require a user-initiated calibration during in vivo use of the analyte sensor.
9 . The system of claim 1 , wherein the drift correction factor is associated with a sensor manufacturing lot.
10 . The system of claim 1 , wherein the factory-determined sensitivity is associated with a sensor manufacturing lot.
11 . The system of claim 1 , wherein the drift correction factor is associated with a sensor manufacturing lot and the factory-determined sensitivity is associated with the sensor manufacturing lot.
12 . The system of claim 1 , wherein the communication link communicates sensor information from the analyte sensor using a Bluetooth communication protocol.
13 . The system of claim 1 , wherein the analyte monitoring system is further configured to determine the analyte levels by transforming uncalibrated analyte data.
14 . The system of claim 13 , wherein the uncalibrated analyte data is transformed with no user intervention.
15 . The system of claim 1 , further comprising a data processing unit, wherein the receiver unit is configured to uniquely identify the data processing unit.
16 . The system of claim 15 , wherein the data processing unit is identified using an identification information of the data processing unit.Join the waitlist — get patent alerts
Track US2021386334A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.